tiprankstipranks
Inspire Medical Systems (INSP)
NYSE:INSP
US Market

Inspire Medical Systems (INSP) Earnings Dates, Call Summary & Reports

Compare
712 Followers

Earnings Data

Report Date
May 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.24
Last Year’s EPS
-0.34
Same Quarter Last Year
Based on 16 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 10, 2025
|
% Change Since: -2.03%
|
Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Positive
The earnings call demonstrated strong financial performance and growth, including achieving profitability and significant revenue increases, particularly internationally. However, the call also highlighted potential challenges, such as the ongoing DOJ investigation and reimbursement complexities with the transition to the Inspire V device. Despite these challenges, the overall outlook remains positive with strong guidance for 2025.
Company Guidance
During the Inspire Medical Systems fourth-quarter and full-year 2024 conference call, management provided guidance for 2025, including a revenue forecast of $940 million to $955 million, representing a 17% to 19% growth year-over-year. The company achieved a 25% revenue increase in Q4 2024 compared to the same period in 2023, totaling $239.7 million. Additionally, Inspire reported its first full year of profitability in 2024, with a diluted net income of $1.75 per share, a significant improvement from a loss of $0.72 per share in 2023. For 2025, they anticipate diluted net income per share to range from $2.10 to $2.20. The gross margin is expected to be between 84% and 86%. Other highlights include a strong operating cash flow of $130 million for the year and a total cash and investment balance of $517 million as of December 31, 2024. The company plans to leverage the Inspire V neurostimulation system, which is expected to reduce surgical time and costs, contributing to their strategic growth and profitability goals for the coming year.
Significant Revenue Growth
Inspire Medical Systems reported a total revenue of $239.7 million for Q4 2024, a 25% increase compared to Q4 2023. The full year revenue for 2024 was $802.8 million, a 28% increase over 2023.
First Full Year of Profitability
Inspire Medical Systems achieved its first full year of profitability in 2024, reporting a net income of $53.5 million compared to a net loss of $21.2 million in 2023.
Strong International Growth
Revenue outside the U.S. was $8.1 million for Q4 2024, marking a 163% increase year-over-year.
Positive Outlook and Guidance for 2025
The company expects full year 2025 revenue to be in the range of $940 million to $955 million, representing 17% to 19% growth year-over-year.
FDA Approval for Inspire V Neurostimulator
Received FDA approval for the Inspire V neurostimulation system designed to improve surgical efficiency and reduce complexity.
---

Inspire Medical Systems (INSP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

INSP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 20252025 (Q1)
-0.24 / -
-0.34
Feb 10, 20252024 (Q4)
0.73 / 1.15
0.49134.69% (+0.66)
Nov 04, 20242024 (Q3)
0.06 / 0.60
-0.29306.90% (+0.89)
Aug 06, 20242024 (Q2)
-0.14 / 0.32
-0.41178.05% (+0.73)
May 07, 20242024 (Q1)
-0.65 / -0.34
-0.5335.85% (+0.19)
Feb 06, 20242023 (Q4)
-0.05 / 0.49
0.1390.00% (+0.39)
Nov 07, 20232023 (Q3)
-0.58 / -0.29
-0.651.67% (+0.31)
Aug 01, 20232023 (Q2)
-0.57 / -0.41
-0.5322.64% (+0.12)
May 02, 20232023 (Q1)
-0.66 / -0.53
-0.6113.11% (+0.08)
Feb 07, 20232022 (Q4)
-0.61 / 0.10
-0.09211.11% (+0.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

INSP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 10, 2025$180.99$183.99+1.66%
Nov 04, 2024$192.71$199.00+3.26%
Aug 06, 2024$147.01$188.38+28.14%
May 07, 2024$245.63$163.41-33.47%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Inspire Medical Systems (INSP) report earnings?
Inspire Medical Systems (INSP) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
    What is Inspire Medical Systems (INSP) earnings time?
    Inspire Medical Systems (INSP) earnings time is at May 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is INSP EPS forecast?
          INSP EPS forecast for the fiscal quarter 2025 (Q1) is -0.24.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis